Beryl Drugs Board Meeting Outcomes FY2026-27

Beryl Drugs held its 1st Board Meeting of FY2026-27 on April 1, 2026, approving multiple governance and operational matters.
EOGM called to regularize appointment of Mr. Shailendra Pathak as Whole Time Director and Mrs. Neha Sarda as Independent Director.
Board approved material Related Party Transactions with M/s. Aminova P. Ltd., where Pathak holds 50% equity, flagging a conflict of interest.
Abhay Bhandari & Associates appointed as Internal Auditor for FY2026-27; Mr. Sudhir Sethi authorized for tender-related document signing.